Sign In
Buy VRTX
$441.74
+13.40 (+3.13%)
At Close: Jun 04, 2026
3 Top-Rated Biotech Stocks That Analysts Are Loving Now
08:48am, Tuesday, 28'th Nov 2023
Investing in biotech stocks is not for risk-averse investors. However, if you're an investor who is serious about generating outsized gains, it's a sector that you can't overlook.
3 Biotech Stocks To Watch Before December 2023
10:38am, Monday, 27'th Nov 2023
Biotech stocks to check out in the stock market today.
5 Stocks You Can Confidently Invest $500 In Right Now
05:30am, Monday, 27'th Nov 2023
Amazon and Apple offer investors a solid growth track record -- and the potential for much more ahead. Add to these a couple of dividend giants and a biotech powerhouse and you have a great selection
This healthcare stock could skyrocket anytime
04:50am, Sunday, 26'th Nov 2023
Vertex Pharmaceuticals (NASDAQ: VRTX) boasts an impressive track record, establishing itself as a leading biotech firm over the last decade. The company has demonstrated a keen emphasis on addressing
2 Healthcare Stocks That Could Help Set You Up for Life
07:00am, Saturday, 25'th Nov 2023
Vertex Pharmaceuticals is an innovative biotech with a robust portfolio and rich pipeline. HCA Healthcare leads an area of the healthcare industry that isn't easy to break into now.
Vertex (VRTX) Gets EU Nod for Kaftrio Use in 2-5 Year Kids
01:32pm, Friday, 24'th Nov 2023
The European Commission approves Vertex's (VRTX) Kaftrio for expanded use to treat children aged two to five years with cystic fibrosis.
Prediction: 3 Stocks That Could Trounce the Market
05:50am, Thursday, 23'rd Nov 2023
Mastercard boasts a strong moat, rock-solid financials, and long-term trends that work in its favor. TransMedics Group is steadily disrupting the multibillion-dollar organ transplant market.
New ETF invested in Ozempic maker and exposed to other obesity drugs falls in first day of trade
08:01am, Wednesday, 22'nd Nov 2023
A new ETF hit the market Tuesday, creating buzz for its exposure to popular weight-loss drugs, while expanding the roster of thematic ETFs available for investors willing to pay up for stock-picking p
Vertex (VRTX) Non-Cystic Fibrosis Pipeline Boosts Stock This Year
07:31am, Tuesday, 21'st Nov 2023
Vertex Pharmaceuticals (VRTX) is likely to achieve multiple clinical milestones in late/2023 and 2024, both in its CF and non-CF portfolio.
Is Vertex Pharmaceuticals Stock a Buy Now?
07:45am, Thursday, 16'th Nov 2023
Vertex Pharmaceuticals' core business is still firing on all cylinders. The biotech is expanding into other areas and diversifying its portfolio.
Vertex Pharmaceuticals Incorporated (VRTX) Jefferies Global Healthcare Conference Call Transcript
04:44pm, Tuesday, 14'th Nov 2023
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX ) Jefferies Global Healthcare Conference Call November 14, 2023 3:30 AM ET Company Participants Stuart Arbuckle - Executive Vice President and Chief Op
Right Now Could Be a Once-in-a-Generation Opportunity to Buy These Cathie Wood Stocks
05:50am, Tuesday, 14'th Nov 2023
Twilio could be poised to use AI to disrupt customer communications. Beam Therapeutics is a pioneer in developing therapies using a highly precise method of gene editing.
Vertex Pharmaceuticals Incorporated (VRTX) Presents at UBS Biopharma Conference (Transcript)
01:50pm, Saturday, 11'th Nov 2023
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX ) UBS Biopharma Conference November 9, 2023 12:00 PM ET Company Participants Charlie Wagner - Executive Vice President & Chief Financial Officer David
1 No-Brainer Stock to Buy and Hold for 10 Years
08:30am, Saturday, 11'th Nov 2023
CRISPR is a leader in the young but promising gene-editing niche. The biotech is getting closer to earning its first major approval.
3 Growth Stocks to Buy Right Now Without Any Hesitation
06:50am, Saturday, 11'th Nov 2023
AbbVie looks like a bargain that has stronger growth on the way. Axsome Therapeutics is in the early innings of what could be an exciting growth story.
